Database
User
| Compound | Dose | Time | Species | Model | Method | Action | Result | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|---|
| Fluorouracil | 0.5 - 800 μM | Colo320; DLD1; HT29; LoVo; SW480 | increase | Positive | 164 | ||||
| Nimesulide | 8 | 24hr | rat | hepatocytes | DNA damage 153 induction (GADD153 antibodies) for ER-stress induced apoptosis | induce | Positive | AC50 (μM) | 40 |
| Bafilomycin A1 | inhibit | Positive | 200 | ||||||
| Bafilomycin A1 | pediatric B ALL cells | induce | Positive | 200 | |||||
| Bafilomycin A1 | induce | Positive | 200 | ||||||
| FOX-988 | increase | Positive | 28 | ||||||
| Sdz-51641 | increase | Positive | 28 | ||||||
| Flufenamic Acid | 68 | 24hr | rat | hepatocytes | DNA damage 153 induction (GADD153 antibodies) for ER-stress induced apoptosis | induce | Positive | AC50 (μM) | 40 |
| Tolfenamic Acid | 50 | 24hr | rat | hepatocytes | DNA damage 153 induction (GADD153 antibodies) for ER-stress induced apoptosis | induce | Positive | AC50 (μM) | 40 |
| Mefenamic acid | 61 | 24hr | rat | hepatocytes | DNA damage 153 induction (GADD153 antibodies) for ER-stress induced apoptosis | induce | Positive | AC50 (μM) | 40 |
| Meloxicam | 153 | 24hr | rat | hepatocytes | DNA damage 153 induction (GADD153 antibodies) for ER-stress induced apoptosis | induce | Positive | AC50 (μM) | 40 |
| Sudoxicam | 223 | 24hr | rat | hepatocytes | DNA damage 153 induction (GADD153 antibodies) for ER-stress induced apoptosis | induce | Positive | AC50 (μM) | 40 |
| Piroxicam | 610 | 24hr | rat | hepatocytes | DNA damage 153 induction (GADD153 antibodies) for ER-stress induced apoptosis | induce | Positive | AC50 (μM) | 40 |
| Diflunisal | 50 | 24hr | rat | hepatocytes | DNA damage 153 induction (GADD153 antibodies) for ER-stress induced apoptosis | induce | Positive | AC50 (μM) | 40 |
| Troglitazone | human | hepatocytes | cell viability assay | induce | Positive | 226 | |||
| Diclofenac | 51 | 24hr | rat | hepatocytes | DNA damage 153 induction (GADD153 antibodies) for ER-stress induced apoptosis | induce | Positive | AC50 (μM) | 40 |
| Sulindac sulfide | 53 | 24hr | rat | hepatocytes | DNA damage 153 induction (GADD153 antibodies) for ER-stress induced apoptosis | induce | Positive | AC50 (μM) | 40 |
| Flufenamic Acid | 70 | 24hr | rat | hepatocytes | cytochrome c release (anti-cytochrome c antibody ) | induce | Positive | AC50 (μM) | 40 |
| apoptolidin | 18 μM | 60 human cancer cell lines of the National Cancer Institute | Positive | mean | 184 | ||||
| cytovaricin | 1 μM | 60 human cancer cell lines of the National Cancer Institute | Positive | mean | 184 | ||||
| Oligomycin | 0.3 μM | 60 human cancer cell lines of the National Cancer Institute | Positive | mean | 184 | ||||
| Tolfenamic Acid | 75 | 24hr | rat | hepatocytes | cytochrome c release (anti-cytochrome c antibody ) | induce | Positive | AC50 (μM) | 40 |
| Mefenamic acid | 277 | 24hr | rat | hepatocytes | cytochrome c release (anti-cytochrome c antibody ) | induce | Positive | AC50 (μM) | 40 |
| Meloxicam | 245 | 24hr | rat | hepatocytes | cytochrome c release (anti-cytochrome c antibody ) | induce | Positive | AC50 (μM) | 40 |
| Sudoxicam | 282 | 24hr | rat | hepatocytes | cytochrome c release (anti-cytochrome c antibody ) | induce | Positive | AC50 (μM) | 40 |
| Piroxicam | 598 | 24hr | rat | hepatocytes | cytochrome c release (anti-cytochrome c antibody ) | induce | Positive | AC50 (μM) | 40 |
| Diflunisal | 79 | 24hr | rat | hepatocytes | cytochrome c release (anti-cytochrome c antibody ) | induce | Positive | AC50 (μM) | 40 |
| Diclofenac | 197 | 24hr | rat | hepatocytes | cytochrome c release (anti-cytochrome c antibody ) | induce | Positive | AC50 (μM) | 40 |
| Sulindac sulfide | 59 | 24hr | rat | hepatocytes | cytochrome c release (anti-cytochrome c antibody ) | induce | Positive | AC50 (μM) | 40 |
| Nimesulide | 21 | 24hr | rat | hepatocytes | cytochrome c release (anti-cytochrome c antibody ) | induce | Positive | AC50 (μM) | 40 |
| Amiodarone | 100 μmol/L | 8 hours | human | HepG2 | Assessment of cytochrome c release | increase | Positive | observable | 4 |
| benzarone | 100 μmol/L | 8 hours | human | HepG2 | Assessment of cytochrome c release | increase | Positive | observable | 4 |
| benzbromarone | 100 μmol/L | 8 hours | human | HepG2 | Assessment of cytochrome c release | increase | Positive | observable | 4 |
| Amiodarone | 100 μmol/L | 8 hours | rat; Sprague–Dawley | hepatocytes | Apoptosis measurement | increase | Positive | p < 0.01 | 4 |
| benzarone | 100 μmol/L | 8 hours | rat; Sprague–Dawley | hepatocytes | Apoptosis measurement | increase | Positive | p < 0.01 | 4 |
| benzbromarone | 100 μmol/L | 8 hours | rat; Sprague–Dawley | hepatocytes | Apoptosis measurement | increase | Positive | p < 0.01 | 4 |
| Amiodarone | 100 μmol/L | 8 hours | rat; Sprague–Dawley | hepatocytes | Apoptosis measurement | increase | Positive | p < 0.05 | 4 |
| benzarone | 100 μmol/L | 8 hours | rat; Sprague–Dawley | hepatocytes | Apoptosis measurement | increase | Positive | p < 0.05 | 4 |
| benzbromarone | 100 μmol/L | 8 hours | rat; Sprague–Dawley | hepatocytes | Apoptosis measurement | increase | Positive | p < 0.01 | 4 |
| Clotrimazole | 30 μmol/L | 24 hours | human | CAL27 | Apoptosis measurement | increase | Positive | p < 0.05 | 5 |
| Clotrimazole | 30 μmol/L | 24 hours | human | SCC25 | Apoptosis measurement | increase | Positive | p < 0.05 | 5 |
| Clotrimazole | 30 μmol/L | 24 hours | human | UM1 | Apoptosis measurement | increase | Positive | p < 0.05 | 5 |
| Clotrimazole | 40 μmol/L | 24 hours | human | CAL27 | Apoptosis measurement | increase | Positive | p < 0.01 | 5 |
| Clotrimazole | 40 μmol/L | 24 hours | human | SCC25 | Apoptosis measurement | increase | Positive | p < 0.01 | 5 |
| Clotrimazole | 40 μmol/L | 24 hours | human | UM1 | Apoptosis measurement | increase | Positive | p < 0.01 | 5 |
| Clotrimazole | 30 μmol/L | 24 hours | human | CAL27 | Apoptosis measurement | increase | Positive | p < 0.05 | 5 |
| Etoposide | isolated mitochondria | increase | Positive | 57 | |||||
| Clotrimazole | 30 μmol/L | 24 hours | human | SCC25 | Apoptosis measurement | increase | Positive | p < 0.05 | 5 |
| Clotrimazole | 30 μmol/L | 24 hours | human | UM1 | Apoptosis measurement | increase | Positive | p < 0.05 | 5 |
| Clotrimazole | 40 μmol/L | 24 hours | human | CAL27 | Apoptosis measurement | increase | Positive | p < 0.01 | 5 |
| Clotrimazole | 40 μmol/L | 24 hours | human | SCC25 | Apoptosis measurement | increase | Positive | p < 0.01 | 5 |
| Clotrimazole | 40 µM | 12 hours | human | CAL27 | western blot | increase | Positive | 2.1875-fold decrease | 5 |
| Clotrimazole | 40 µM | 12 hours | human | UM1 | western blot | increase | Positive | 1.35-fold decrease | 5 |
| Clotrimazole | 40 µM | 24 hours | human | CAL27 | western blot | increase | Positive | 3.1818-fold decrease | 5 |
| Clotrimazole | 40 µM | 24 hours | human | UM1 | western blot | increase | Positive | 1.5-fold decrease | 5 |
| Clotrimazole | 40 µM | 48 hours | human | CAL27 | western blot | increase | Positive | 3.3333-fold decrease | 5 |
| Clotrimazole | 40 µM | 48 hours | human | UM1 | western blot | increase | Positive | 1.5882-fold decrease | 5 |
| Clotrimazole | 40 µM | 12 hours | human | CAL27 | western blot | increase | Positive | 1.3953-fold increase | 5 |
| Clotrimazole | 40 µM | 24 hours | human | CAL27 | western blot | increase | Positive | 1.3953-fold increase | 5 |
| Clotrimazole | 40 µM | 24 hours | human | UM1 | western blot | increase | Positive | 1.2623-fold increase | 5 |
| Clotrimazole | 40 µM | 48 hours | human | CAL27 | western blot | increase | Positive | 2.3256-fold increase | 5 |
| Clotrimazole | 40 µM | 48 hours | human | UM1 | western blot | increase | Positive | 1.6223-fold increase | 5 |
| Clotrimazole | 150 mg/kg/day | 6 days a week for two weeks | human | CAL27(xenograft tumors)/mouse | Immunohistochemistry | increase | Positive | 1.5-fold decrease | 5 |
| Clotrimazole | 150 mg/kg/day | 6 days a week for two weeks | human | CAL27(xenograft tumors)/mouse | western blot analysis | increase | Positive | 2.0-fold increase | 5 |
| p,p'-ddt | 30 μM | rat | Sertoli cells | induce | Positive | 242 | |||
| Rotenone | 0.1–0.5 nmol/mg protein | Wistar rat brain isolated mitochondria | Positive | 242 | |||||
| erastin | 10μM | inducer | Positive | 245 | |||||
| deferoxamine | 100μM | inhibitor | Positive | 245 | |||||
| cycloheximide | ferroptosis weak rescue | inhibitor | Positive | 245 | |||||
| U0126 | inhibitor | Positive | 245 | ||||||
| trolox | inhibitor | Positive | 245 | ||||||
| N-deacetyl ketoconazole | 120 μM | 0.5 hours | rat | hepatocytes | Measurement of LDH activities | increase | Positive | p < 0.05 | 8 |
| N-deacetyl ketoconazole | 160 μM | 0.5 hours | rat | hepatocytes | Measurement of LDH activities | increase | Positive | p < 0.05 | 8 |
| mimosine | 0.3 mM | U-937 leukemia cell line. | Positive | 270 | |||||
| N-deacetyl ketoconazole | 120 μM | 1 hours | rat | hepatocytes | Measurement of LDH activities | increase | Positive | p < 0.05 | 8 |
| N-deacetyl ketoconazole | 160 μM | 1 hours | rat | hepatocytes | Measurement of LDH activities | increase | Positive | p < 0.05 | 8 |
| N-deacetyl ketoconazole | 80 μM | 2 hours | rat | hepatocytes | Measurement of LDH activities | increase | Positive | p < 0.05 | 8 |
| N-deacetyl ketoconazole | 120 μM | 2 hours | rat | hepatocytes | Measurement of LDH activities | increase | Positive | p < 0.05 | 8 |
| N-deacetyl ketoconazole | 160 μM | 2 hours | rat | hepatocytes | Measurement of LDH activities | increase | Positive | p < 0.05 | 8 |
| N-deacetyl ketoconazole | 60 μM | 4 hours | rat | hepatocytes | Measurement of LDH activities | increase | Positive | p < 0.05 | 8 |
| N-deacetyl ketoconazole | 80 μM | 4 hours | rat | hepatocytes | Measurement of LDH activities | increase | Positive | p < 0.05 | 8 |
| N-deacetyl ketoconazole | 120 μM | 4 hours | rat | hepatocytes | Measurement of LDH activities | increase | Positive | p < 0.05 | 8 |
| N-deacetyl ketoconazole | 160 μM | 4 hours | rat | hepatocytes | Measurement of LDH activities | increase | Positive | p < 0.05 | 8 |
| N-deacetyl ketoconazole | 120 μM | 0.5 hours | rat | hepatocytes | Measurement of LDH activities; co-treatment of 250 μM n-Octylamine | increase | Positive | p < 0.05 | 8 |
| N-deacetyl ketoconazole | 120 μM | 0.5 hours | rat | hepatocytes | Measurement of LDH activities; co-treatment of 100 μM Methimazole | affect | Positive | p < 0.05 | 8 |
| N-deacetyl ketoconazole | 120 μM | 1 hours | rat | hepatocytes | Measurement of LDH activities; co-treatment of 250 μM n-Octylamine | increase | Positive | p < 0.05 | 8 |
| N-deacetyl ketoconazole | 120 μM | 1 hours | rat | hepatocytes | Measurement of LDH activities; co-treatment of 100 μM Methimazole | affect | Positive | p < 0.05 | 8 |
| N-deacetyl ketoconazole | 160 μM | 1 hours | rat | hepatocytes | Measurement of LDH activities; co-treatment of 250 μM n-Octylamine | increase | Positive | p < 0.05 | 8 |
| N-deacetyl ketoconazole | 160 μM | 1 hours | rat | hepatocytes | Measurement of LDH activities; co-treatment of 100 μM Methimazole | affect | Positive | p < 0.05 | 8 |
| Rotenone | 1µM | overnight | HeLa cells | Cyto-ID Autophagy Detection dye and Autophagy compound library in a microplate-based assay | induce | Positive | >2 fold increase | 277 | |
| nocodazole | 1µM | overnight | HeLa cells | Cyto-ID Autophagy Detection dye and Autophagy compound library in a microplate-based assay | induce | Positive | >2 fold increase | 277 | |
| Chloroquine | 1µM | overnight | HeLa cells | Cyto-ID Autophagy Detection dye and Autophagy compound library in a microplate-based assay | induce | Positive | >2 fold increase | 277 | |
| Brefeldin A | 1µM | overnight | HeLa cells | Cyto-ID Autophagy Detection dye and Autophagy compound library in a microplate-based assay | induce | Positive | >2 fold increase | 277 | |
| Tunicamycin | 1µM | overnight | HeLa cells | Cyto-ID Autophagy Detection dye and Autophagy compound library in a microplate-based assay | induce | Positive | >2 fold increase | 277 | |
| thapsigargin | 1µM | overnight | HeLa cells | Cyto-ID Autophagy Detection dye and Autophagy compound library in a microplate-based assay | induce | Positive | >2 fold increase | 277 | |
| Gingerol | 1µM | overnight | HeLa cells | Cyto-ID Autophagy Detection dye and Autophagy compound library in a microplate-based assay | induce | Positive | >2 fold increase | 277 | |
| Staurosporine | 1µM | overnight | HeLa cells | Cyto-ID Autophagy Detection dye and Autophagy compound library in a microplate-based assay | induce | Positive | >2 fold increase | 277 | |
| Clotrimazole | 40 μmol/L | 24 hours | human | UM1 | Apoptosis measurement | increase | Positive | p < 0.01 | 5 |
| oxaliplatin | Positive | 262 | |||||||
| MG-132 | 20 μM | 24 hr | rat | PC12 cells | Measurement of caspase-3 activity with ApoAlert™ CPP32/Caspase-3 assay kit | increase | Positive | 289 | |
| MG-132 | 20 μM | 24 hr | rat | PC12 cells | Measurement of cytochrome c release using a solid-phase, enzyme-linked immunosorbent assay kit for the detection of cytochrome c. | increase | Positive | 289 | |
| Troglitazone | 100 µM | 24hr | HepG2 cells | Apo-One homogeneous caspase 3 assay kit | Positive | 330 | |||
| Niclosamide | induce | Positive | 294 | ||||||
| Dequalinium Chloride | 24 hr | Ishikawa and Caco-2 | WB was performed to measure the BCL-XL and released cytochrome c proteins from mitochondria; Caspase-3/7 activity was measured using the Caspase-Glo 3/7 reagent from the ApoTox-Glo Triplex Assay kit | induce | Positive | 299 | |||
| Cisplatin | 24 hr | Ishikawa and Caco-2 | WB was performed to measure the BCL-XL and released cytochrome c proteins from mitochondria; Caspase-3/7 activity was measured using the Caspase-Glo 3/7 reagent from the ApoTox-Glo Triplex Assay kit | induce | Positive | 299 | |||
| Cadmium | 100, 500 μM | 30 min | rat | PC12 cells | measured spectrofluorometrically using the fluorescent dye dichlorodihydrofluorescein diacetate (DCFH2-DA) as the ROS-sensitive probe | induce | Positive | 300 | |
| Mercury | 10-500 μM | 30min | rat | PC12 cells | measured spectrofluorometrically using the fluorescent dye dichlorodihydrofluorescein diacetate (DCFH2-DA) as the ROS-sensitive probe | induce | Positive | 300 | |
| Copper | 10-500 μM | 3hr | rat | PC12 cells | measured spectrofluorometrically using the fluorescent dye dichlorodihydrofluorescein diacetate (DCFH2-DA) as the ROS-sensitive probe | induce | Positive | 300 | |
| Copper | 500 μM | 24 hr | rat | PC12 cells | measured spectrofluorometrically using the fluorescent dye dichlorodihydrofluorescein diacetate (DCFH2-DA) as the ROS-sensitive probe | induce | Positive | 300 | |